Workit Health

Closing our 2024 expansion out with a bang, today we've launched our Montana telehealth clinic for opioid and alcohol use disorders. According to the Montana Department of Public Health and Human Services, opioid overdoses in the state have more than doubled from 2014-2023. Additionally, Montana reports a binge drinking rate 7% higher than the national average. Via our app-based programs, residents all over Montana can now receive evidence-based care as soon as they're ready. Residents of Montana can receive effective medications like buprenorphine and naltrexone, and can connect with licensed clinicians, behavioral health staff, and fellow members of Workit Health via video appointments and online recovery groups. Our providers also offer care for several commonly co-occurring conditions like anxiety, depression, insomnia, and hepatitis C, and prescribe PrEP for HIV. Workit Health’s programs have helped more than 30k members since our founding in 2015, and we're thrilled to bring low-barrier, non-judgmental treatment options to Big Sky Country. https://lnkd.in/g7-VRV8P

Today we're launching our Arizona clinic, with 100% online treatment for opioid and alcohol use disorders via our app-based telehealth program. Medication for opioid use disorder (MOUD) is known to be safe and effective, significantly reducing overdose rates and improving outcomes. Despite this, a 2022 "secret shopper" study found that only 36% of Arizonan MOUD providers on government-maintained lists were actually providing medication. This creates a barrier to care that Workit Health’s accessible, online treatment programs can now help to overcome. With the addition of Arizona, Workit Health now serves 8 states with at-home, evidence-based addiction care. Alongside clinical care for opioid and alcohol use disorders, our providers also treat several common co-occurring conditions like anxiety, depression, insomnia, and hepatitis C. We're proud to offer Arizonans with substance use disorders a convenient, judgment-free way to support their recovery. Our online programs include working with licensed clinicians, behavioral health staff, and fellow members of Workit Health via video appointments and online recovery groups. https://lnkd.in/gQW6ptUS

🚨 Alert to Job Seekers 🚨 We've recently heard from people who have received phishing emails with fake interview requests and offer letters from Workit Health. This is a scam. Here’s how to identify legitimate communication from us: ✅ Workit Health only sends phone interview requests through our Jobvite platform. 🛑 We DO NOT use the following email: [email protected]. 🛑 We DO NOT request interviews through Microsoft Teams. 🛑 We DO NOT request sensitive personal information before a thorough interview process and offer. 🛑 We DO NOT ever ask for money from our candidates. If you suspect someone fraudulently claiming to represent Workit Health has contacted you: ⚠️ Do not engage or provide personal information. ⚠️ Report the email as a pushing attempt to your email provider and report it as internet fraud to the Internet Crime Complaint Center here: https://www.ic3.gov/ We are investigating this issue. Stay vigilant, keep yourself safe, and always verify before responding.

Thank you to Nathan Menke M.D., Ph.D., who led November's Grand Rounds on the topic of "Buprenorphine Tapering." Dr. Menke is board certified in Addiction Medicine, Emergency Medicine, and Medical Toxicology. He earned his MD from The Ohio State University and his PhD in Biochemsitry and Molecular Biology from Virginia Commonwealth University. Dr. Menke is a clinical assistant professor at the University of Michigan Medical School and serves as the Medical Director of Inpatient Addiction Consult Services at Michigan Medicine. He provides treatment for patients suffering from substance use disorders in the inpatient setting as part of the Addiction Consult Team. To learn more about Dr. Menke's work in another aspect of addiction medicine, you can review Michigan Medicine's recently published guidelines, "Alcohol Withdrawal in Hospitalized Patients: Michigan Alcohol Withdrawal Severity (MAWS) Protocol," on which he was an author: https://lnkd.in/gefp5Ny7 Workit Health has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit to PAs and NPs who participate in Grand Rounds. All Workit Health staff are welcome to attend these educational sessions.

We're excited to announce the launch of our new telehealth outpatient clinic in Oklahoma, providing evidence-based addiction care across the state. According to the Oklahoma Department of Mental Health and Substance Abuse Services, 16.1% of the state's adult population has a substance use disorder. Of those 700,000 and 950,000 Oklahomans who need treatment and support, few receive it. Workit Health’s programs can be part of the solution to this unmet need. We have reached more than 30k members since our founding in 2015, and we've served Oklahoma’s neighboring state Texas since 2021. We're proud to bring low-barrier, non-judgmental treatment options to the Sooner State. Workit Health’s online addiction treatment programs offer effective, clinical care for opioid and alcohol use, and treat several common co-occurring conditions like anxiety, depression, insomnia, and hepatitis C. Now residents of Oklahoma from the ranches to the City can receive safe and effective medications like buprenorphine and naltrexone, that support their recovery. Our online programs include working with licensed clinicians, behavioral health staff, and fellow members of Workit Health via video appointments and online recovery groups. https://lnkd.in/guxG-jdv

Health issues and technological innovation are global concerns. That's why Workit Health CMO M. Justin Coffey, MD, DFAPA, FANPA, CHCIO is speaking at Health Tech Forward 2024 in Barcelona this week, on December 5th. Together with Johannes Blaschke of Calm/Storm, Marta Garcia Manrique of Servier, and Patricia Ripoll Ros of Fundación VISIBLE, Dr. Coffey will be discussing, "In our "patient first" era: shared decisions, trust and tailored care solutions." We're excited to learn from this eclectic panel. https://lnkd.in/diadRzv #HTF2024

The DEA has announced its third temporary extension of telehealth flexibilities for prescribing controlled medications. What does this mean for the future of telehealth addiction treatment? On our partners blog, The Workit Way, Cynthia Jimes, Ph.D. and Marlene C. Lira discuss the implications and limitations of this temporary extension, which will remain in effect until the end of 2025. As buprenorphine is a crucial part of treatment for many people with opioid use disorder, this rule profoundly affects telehealth addiction treatment providers like Workit Health and our members. Click the link to read "The Third Extension of Telehealth Flexibilities—Implications and Limitations" https://lnkd.in/g2hf6W7c #telehealth #addictionmedicine #harmreduction

“Instead of us asking how effective [non-opioid medications] are at helping relieve symptoms of withdrawal, I recommend we ask why someone would be recommended to receive these or would want to receive these rather than use the medications – buprenorphine or methadone – that effectively treat withdrawal and the underlying brain chemistry present in an opioid use disorder,” Dr. Eileen Barrett, senior medical director and vice president of quality at Workit Health, told Addiction Treatment Business. Dr. Eileen B., Senior Medical Director & VP of Quality at Workit Health, spoke with Behavioral Health Business about medication for opioid use disorder (OUD), and why some providers hesitate to prescribe buprenorphine and methadone. Buprenorphine and methadone have been demonstrated to be the most effective treatment for OUD, but the fact that they are opioid-based gives some providers pause. We love to see providers and journalists speaking out about this stigma that—even within the medical community—can rear its head to keep patients from getting the care they need. We wholeheartedly agree with Dr. Barrett that, "To help more patients with OUD receive gold-standard care, recovery communities should embrace the use of buprenorphine or methadone." https://lnkd.in/g7t-xhd5

Workit Health is proud to serve New Mexico with the launch of our telehealth outpatient clinic in the Land of Enchantment, providing evidence-based addiction care across the state. Workit Health’s online addiction treatment programs offer clinical care for opioid and alcohol use, as well as several commonly co-occurring conditions like anxiety, depression, insomnia, and hepatitis C. Residents of New Mexico can receive effective medications like buprenorphine and naltrexone, and can connect with licensed clinicians, behavioral health staff, and fellow members of Workit Health via video appointments and online recovery groups. Workit Health’s programs have reached more than 30k members since our founding in 2015, and we've served New Mexico’s neighboring state Texas since 2021. We're thrilled to bring low-barrier, non-judgmental treatment options to New Mexico. https://lnkd.in/g3VGMMy3

Workit Health CMO M. Justin Coffey, MD, DFAPA, FANPA, CHCIO will be speaking at Health Tech Forward 2024 in Barcelona on December 5th. Dr. Coffey is taking part in a panel discussing, "In our "patient first" era: shared decisions, trust and tailored care solutions" alongside Johannes Blaschke of Calm/Storm, Marta Garcia Manrique of Servier, and Patricia Ripoll Ros of Fundación VISIBLE. Learn more about this exciting European conference for health tech innovation and investment here: https://lnkd.in/diadRzv #HTF2024